231 related articles for article (PubMed ID: 28523478)
41. Bruton's Tyrosine Kinase mediates platelet receptor-induced generation of microparticles: a potential mechanism for amplification of inflammatory responses in rheumatoid arthritis synovial joints.
Hsu J; Gu Y; Tan SL; Narula S; DeMartino JA; Liao C
Immunol Lett; 2013 Feb; 150(1-2):97-104. PubMed ID: 23266841
[TBL] [Abstract][Full Text] [Related]
42. Platelet glycoprotein VI cluster size is related to thrombus formation and phosphatidylserine exposure in collagen-adherent platelets under arterial shear.
Jooss NJ; Smith CW; Pike JA; Farndale RW; Henskens YMC; Watson SP; Heemskerk JWM; Poulter NS
J Thromb Haemost; 2023 Aug; 21(8):2260-2267. PubMed ID: 37150294
[TBL] [Abstract][Full Text] [Related]
43. Dimers of the platelet collagen receptor glycoprotein VI bind specifically to fibrin fibers during clot formation, but not to intact fibrinogen.
Moroi M; Induruwa I; Farndale RW; Jung SM
J Thromb Haemost; 2021 Aug; 19(8):2056-2067. PubMed ID: 34032355
[TBL] [Abstract][Full Text] [Related]
44. Fibrin exposure triggers αIIbβ3-independent platelet aggregate formation, ADAM10 activity and glycoprotein VI shedding in a charge-dependent manner.
Montague SJ; Hicks SM; Lee CS; Coupland LA; Parish CR; Lee WM; Andrews RK; Gardiner EE
J Thromb Haemost; 2020 Jun; 18(6):1447-1458. PubMed ID: 32198957
[TBL] [Abstract][Full Text] [Related]
45. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
Karnicki K; Leadley RJ; Baxi S; Peterson T; Wysokinski W; McBane RD
Thromb Haemost; 2008 Apr; 99(4):759-66. PubMed ID: 18392334
[TBL] [Abstract][Full Text] [Related]
46. An anti-von Willebrand factor aptamer reduces platelet adhesion among patients receiving aspirin and clopidogrel in an ex vivo shear-induced arterial thrombosis.
Arzamendi D; Dandachli F; Théorêt JF; Ducrocq G; Chan M; Mourad W; Gilbert JC; Schaub RG; Tanguay JF; Merhi Y
Clin Appl Thromb Hemost; 2011; 17(6):E70-8. PubMed ID: 21078615
[TBL] [Abstract][Full Text] [Related]
47. Application of ex vivo flow chamber system for assessment of stent thrombosis.
Sakakibara M; Goto S; Eto K; Tamura N; Isshiki T; Handa S
Arterioscler Thromb Vasc Biol; 2002 Aug; 22(8):1360-4. PubMed ID: 12171801
[TBL] [Abstract][Full Text] [Related]
48. Role of SHP2 (PTPN11) in glycoprotein VI-dependent thrombus formation: Improved platelet responsiveness by the allosteric drug SHP099 in Noonan syndrome patients.
Fernández DI; Diender M; Hermida-Nogueira L; Huang J; Veiras S; Henskens YMC; Te Loo MWM; Heemskerk JWM; Kuijpers MJE; García Á
Thromb Res; 2023 Aug; 228():105-116. PubMed ID: 37302266
[TBL] [Abstract][Full Text] [Related]
49. Flow cytometric observations on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb-IIIa.
Christopoulos C; Mackie I; Lahiri A; Machin S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):729-37. PubMed ID: 8292722
[TBL] [Abstract][Full Text] [Related]
50. Ex vivo--in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A.
Klinkhardt U; Kirchmaier CM; Westrup D; Graff J; Mahnel R; Breddin HK; Harder S
Clin Pharmacol Ther; 2000 Mar; 67(3):305-13. PubMed ID: 10741635
[TBL] [Abstract][Full Text] [Related]
51. Direct observation of platelet adhesion to fibrinogen- and fibrin-coated surfaces.
Jen CJ; Lin JS
Am J Physiol; 1991 Nov; 261(5 Pt 2):H1457-63. PubMed ID: 1951733
[TBL] [Abstract][Full Text] [Related]
52. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
[TBL] [Abstract][Full Text] [Related]
53. Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity.
Loyau S; Dumont B; Ollivier V; Boulaftali Y; Feldman L; Ajzenberg N; Jandrot-Perrus M
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):778-85. PubMed ID: 22155453
[TBL] [Abstract][Full Text] [Related]
54. Impact of glycoprotein VI and platelet adhesion on atherosclerosis--a possible role of fibronectin.
Bültmann A; Li Z; Wagner S; Peluso M; Schönberger T; Weis C; Konrad I; Stellos K; Massberg S; Nieswandt B; Gawaz M; Ungerer M; Münch G
J Mol Cell Cardiol; 2010 Sep; 49(3):532-42. PubMed ID: 20430036
[TBL] [Abstract][Full Text] [Related]
55. Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands.
Snell DC; Schulte V; Jarvis GE; Arase K; Sakurai D; Saito T; Watson SP; Nieswandt B
Biochem J; 2002 Nov; 368(Pt 1):293-300. PubMed ID: 12117414
[TBL] [Abstract][Full Text] [Related]
56. Fibrin and D-dimer bind to monomeric GPVI.
Onselaer MB; Hardy AT; Wilson C; Sanchez X; Babar AK; Miller JLC; Watson CN; Watson SK; Bonna A; Philippou H; Herr AB; Mezzano D; Ariëns RAS; Watson SP
Blood Adv; 2017 Aug; 1(19):1495-1504. PubMed ID: 29296791
[TBL] [Abstract][Full Text] [Related]
57. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo.
Massberg S; Gawaz M; Grüner S; Schulte V; Konrad I; Zohlnhöfer D; Heinzmann U; Nieswandt B
J Exp Med; 2003 Jan; 197(1):41-9. PubMed ID: 12515812
[TBL] [Abstract][Full Text] [Related]
58. A humanized glycoprotein VI (GPVI) mouse model to assess the antithrombotic efficacies of anti-GPVI agents.
Mangin PH; Tang C; Bourdon C; Loyau S; Freund M; Hechler B; Gachet C; Jandrot-Perrus M
J Pharmacol Exp Ther; 2012 Apr; 341(1):156-63. PubMed ID: 22238212
[TBL] [Abstract][Full Text] [Related]
59. Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen-Induced Platelet Aggregation.
Renaud L; Lebozec K; Voors-Pette C; Dogterom P; Billiald P; Jandrot Perrus M; Pletan Y; Machacek M
J Clin Pharmacol; 2020 Sep; 60(9):1198-1208. PubMed ID: 32500636
[TBL] [Abstract][Full Text] [Related]
60. Glycoprotein VI is associated with GPIb-IX-V on the membrane of resting and activated platelets.
Arthur JF; Gardiner EE; Matzaris M; Taylor SG; Wijeyewickrema L; Ozaki Y; Kahn ML; Andrews RK; Berndt MC
Thromb Haemost; 2005 Apr; 93(4):716-23. PubMed ID: 15841318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
